Hans Henrik Munch-Jensen
Vorstandsvorsitzender bei Munch ApS
Ursprung des Netzwerks ersten Grades von Hans Henrik Munch-Jensen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
23
| Public Company | Pharmaceuticals: Major | 23 |
University of Aarhus
21
| College/University | Other Consumer Services | 21 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hans Henrik Munch-Jensen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| Y-MABS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | President Director of Finance/CFO Chairman | |
| CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
| MONSENSO A/S | Internet Software/Services | Director/Board Member Director/Board Member | |
Falck Danmark A/S
 Falck Danmark A/S Other TransportationTransportation Falck Danmark A/S offers ambulance service, fire fighting, roadside assistance, and non-emergency patient transport. The company was founded on October 3, 1906 and is headquartered in Copenhagen, Denmark. | Other Transportation | Chief Executive Officer Director/Board Member | |
| Princeton University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| TDC A/S | Major Telecommunications | Chairman Chief Executive Officer | |
| BANG & OLUFSEN A/S | Electronics/Appliances | Director/Board Member Director of Finance/CFO | |
| JYSKE BANK A/S | Major Banks | Chairman Corporate Officer/Principal | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Founder | |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Chairman Founder | |
Jyske Realkredit A/S
 Jyske Realkredit A/S Finance/Rental/LeasingFinance Jyske Realkredit A/S operates as a mortgage credit institutions. It offers loans secured by collateral for residential and corporate purposes ranging from private rental and cooperative housing to office and business properties. The company was founded in 1797 and is headquartered in Kongens Lyngby, Denmark. | Finance/Rental/Leasing | Director/Board Member Chairman | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| ORSTED A/S | Electric Utilities | Corporate Officer/Principal Corporate Officer/Principal | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Graduate Degree | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Director/Board Member | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | Chairman General Counsel | |
| Lundbeck Cognitive Therapeutics A/S | Director/Board Member Chairman | ||
Ingram Micro Mobility Denmark A/S
 Ingram Micro Mobility Denmark A/S Telecommunications EquipmentElectronic Technology Ingram Micro Mobility Denmark A/S wholesale of electronic components and telecommunications equipment and parts. The company was founded on February 15, 1984 and is headquartered in Kolding, Denmark. | Telecommunications Equipment | Chief Operating Officer Chairman | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aalborg | College/University | Graduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Hilti Denmark A/S | Corporate Officer/Principal | ||
Aimvion A/S
 Aimvion A/S Pharmaceuticals: MajorHealth Technology Aimvion A/S provides services for autoimmune diseases and biotechnology. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| ROS-Therapeutics ApS | Chief Executive Officer | ||
| CATALENT, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CURASIGHT A/S | Medical Specialties | Chief Operating Officer | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
Catalent Germany Schorndorf GmbH
 Catalent Germany Schorndorf GmbH Pharmaceuticals: MajorHealth Technology Part of Catalent, Inc., Catalent Germany Schorndorf GmbH is a pharmaceutical manufacturing company. The company is based in Schorndorf, Germany. The CEOs of the company are Thilo Widmayer, Roel de Nobel, Barry B. Littlejohns, Wetteny Joseph. | Pharmaceuticals: Major | Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Dänemark | 33 |
| Vereinigte Staaten | 13 |
| Deutschland | 3 |
| Niederlande | 3 |
| Norwegen | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 9 |
| Commercial Services | 3 |
| Communications | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 248 |
| Corporate Officer/Principal | 132 |
| Chairman | 104 |
| Chief Executive Officer | 57 |
| Independent Dir/Board Member | 48 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Thorleif Krarup | 28 |
| Claus Tycho Bræstrup | 27 |
| Peter Andersen | 26 |
| Anders Gersel Pedersen | 24 |
| Lise Kingo | 23 |
| Mats Gunnar Pettersson | 23 |
| Kim Fausing | 23 |
| Burt Malkiel | 22 |
| Peter Thostrup | 21 |
| Pernille Erenbjerg | 21 |
| Hans Jacob Carstensen | 20 |
| Peter Henrik Kürstein-Jensen | 19 |
| Niels Erik Jakobsen | 18 |
| Kurt Bligaard Pedersen | 17 |
| Paolo Augusto Paoletti | 13 |
- Börse
- Insiders
- Hans Henrik Munch-Jensen
- Unternehmensverbindungen
